Atlas Trials

Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects

Clinical trial NCT00146328 · COMPLETED

Trial details

NCT number
NCT00146328
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HIV Infections
Start date
2001-04-01
Primary completion
2008-05-01
Enrollment
997

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.